HIMSHIGH SIGNALFINANCIAL10-K

HIMS experienced explosive growth with 59% revenue increase to $2.3B, but total liabilities surged 599% to $1.6B, creating a significant balance sheet transformation that warrants immediate investor attention.

The massive 599% increase in total liabilities alongside strong revenue growth suggests either major debt financing, acquisition activity, or significant operational changes that fundamentally altered the company's capital structure. While operational performance appears strong with 71% operating income growth, the dramatic liability increase could indicate elevated financial risk or leverage that investors need to understand and monitor closely.

Comparing 2026-02-23 vs 2025-02-24View on EDGAR →
FINANCIAL ANALYSIS

HIMS delivered robust top-line growth with revenue increasing 59% to $2.3B and operating income surging 71% to $105.6M, demonstrating strong operational execution and scaling efficiency. However, the balance sheet transformation is striking, with total assets more than doubling to $2.2B while total liabilities exploded 599% to $1.6B, suggesting major financing activities or structural changes. The combination of strong operational performance with dramatic balance sheet expansion signals a company in rapid transformation, but the massive liability increase creates new financial risk considerations that overshadow the positive operational metrics.

FINANCIAL STATEMENT CHANGES
Total Liabilities
Balance Sheet
+599.1%
$230.8M$1.6B

Liabilities grew 599.1% — significant increase in debt or obligations, assess impact on financial flexibility.

Accounts Receivable
Balance Sheet
+426.2%
$6.1M$32.1M

Receivables surged 426.2% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Total Assets
Balance Sheet
+204.5%
$707.5M$2.2B

Asset base grew 204.5% — expansion through organic growth, acquisitions, or capital deployment.

SG&A Expense
P&L
+179.9%
$65.6M$183.6M

SG&A up 179.9% — significant increase in sales or administrative costs, monitor impact on operating leverage.

Current Assets
Balance Sheet
+93.9%
$395.8M$767.6M

Current assets grew 93.9% — improving short-term liquidity or inventory/receivables build.

Current Liabilities
Balance Sheet
+82.7%
$221.4M$404.4M

Current liabilities surged 82.7% — significant near-term obligations; verify ability to meet short-term debt.

Operating Income
P&L
+70.6%
$61.9M$105.6M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Revenue
P&L
+59%
$1.5B$2.3B

Strong top-line growth of 59% — accelerating demand or successful expansion into new markets.

Gross Profit
P&L
+47.8%
$1.2B$1.7B

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Inventory
Balance Sheet
+24.4%
$64.4M$80.1M

Inventory built 24.4% — monitor whether demand supports this build or if write-downs may follow.

LANGUAGE CHANGES
NEW — 2026-02-23
PRIOR — 2025-02-24
ADDED
As of February 20, 2026, 219,561,143 shares of Class A common stock, par value $0.0001, and 8,377,623 shares of Class V common stock, par value $0.0001, were issued and outstanding.
The Hims Hers platforms (collectively, our platform ) include access to a highly-qualified and technologically-innovative provider network, an electronic medical record system designed to support providers and customers, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities.
Our digital platform enables access to treatments for a broad range of chronic conditions, including those related to sexual health, hair loss, hormone health, weight loss, dermatology, and mental health, as well as services such as comprehensive laboratory testing.
Hims Hers connects patients to licensed healthcare professionals who can prescribe medications when appropriate, including through personalized treatment plans, with prescriptions fulfilled online through licensed pharmacies.
In addition, we also offer access to a range of non-prescription health and wellness products.
+7 more — sign up free →
REMOVED
As of February 21, 2025, 213,787,949 shares of Class A common stock, par value $0.0001, and 8,377,623 shares of Class V common stock, par value $0.0001, were issued and outstanding.
The Hims Hers platform includes access to a highly-qualified and technologically-innovative provider network, a clinically-focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities.
Our digital platform enables access to treatments for a broad range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss.
Hims Hers connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis.
In addition, we also offer access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →